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SUMMARY
Total hip arthroplasty may be followed by ectopic bone formation. An increased frequency has been
suspected in patients with diffuse idiopathic skeletal hyperostosis (DISH). In 204 patients we found that, of
the 38 subjects with pre-existing DISH, 29% developed postoperative ossification compared with only
10% in those without DISH (p < 0.01). DISH is therefore a risk factor for postoperative ectopic bone
formation. In a separate study of 1325 patients (not analysed for spinal DISH), we looked for correlations
between the severity of postoperative ectopic bone and clinical measurements. Even for the more severe
ossification grades (n = 112), only 10% reported serious pain and only 26% had reduced hip flexion
(<70°). Thus, periprosthetic ectopic bone is not sufficiently important to justify the routine use of
preventative drugs such as bisphosphonates in patients with DISH undergoing total hip replacement.
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THE formation of periprosthetic ectopic cal-
cification and ossification in the first months fol-
lowing total hip replacement arthroplasty is well
known. (In this paper we will use only the term
'ossification'. Persistent calcification usually
becomes trabecular with time.) Reports of its
frequency vary. A notable degree of periarticu-
lar postoperative ossification was seen in 5% of
Charnley's patients [1]. Others have reported
frequencies of 8-90% [2-6].
No consensus is found in the literature about
the clinical significance of this abnormality in
terms of pain or reduced motion (ROM). How-
ever, symptoms seem to occur in 1-5%, especi-
ally loss of movement [7].
Predisposing factors which have been exam-
ined include operative technique, haemorrhage
and infection [ 1,8,9]. DeLee et al. [3] stated that
the degree of preoperative reduced ROM influ-
enced the amount of postoperative ossification.
Male sex, osteoarthritis, hyperglycaemia and
obesity are other factors which have been
incriminated [2, 10-12]. Several authors have
suggested that DISH (formerly called For-
estier's disease) might be a risk factor (Fig. 1) [2,
13-16], others have denied any influence of
DISH [17].
The objective of this retrospective radiologi-
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cal and clinical study was to elucidate two ques-
tions. First, do patients with pre-existing spinal
hyperostosis develop ectopic bone more fre-
quently around their hip arthroplasty than con-
trols without DISH? Second, are such bone
formations associated with serious pain or
restricted hip function?
PATIENTS AND METHODS
There were two groups of patients:
Group I consisted of 204 consecutive patients
with an original M.E. Muller straight-stem pros-
thesis, operated on in the years 1977/1978 (sub-
group la, n = 91) and 1979/1980 (subgroup Ib, n
= 113), respectively. They all underwent sur-
FtG. 1.—Typical flowing ossification in a 67-year-old male
with DISH on the spine. Within 2 years (left to right), a
new lateral bridge developed between L2 and L3.
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TABLE I
CLASSIFICATION FOR ECTOPIC PERI PROSTHETIC BONE
FORMATION*
Class I: Islands of bone within the soft tissues about
the hip.
Class II: Bone spurs from the pelvis or proximal end of
the femur, leaving at least 1 cm between
opposing surfaces.
Class III: Bone spurs from the pelvis or proximal end of
the femur, reducing the space between oppos-
ing bone surfaces to less than 1 cm.
Class IV: Apparent bone ankylosis of the hip.
* After Brooker el al. [4].
gery in the University Ginic for Orthopaedic
Surgery in Bern. These patients were followed
up after 5 years in 1983 and 1985, respectively.
Of the 204 patients 117 were men with a mean
age of 67±8 (range 43-84) years at follow-up,
and 87 were women, mean age 70±10 (range
35-S9).
Group II consisted of 1325 patients with a
Muller prosthesis, operated on in different Swiss
clinics for orthopaedic surgery and examined
again after 1 year (mean age: men 64±9; women
66±11).
Radiological investigation
At the 5-year follow-up, all the patients of
group / had an anteroposterior radiograph of the
pelvis. In addition, patients in subgroup la (n =
91) had anteroposterior (AP) and lateral radio-
gTaphs of the thoracic and/or lumbar spine.
Those of subgroup Ib (n = 113) had AP and
lateral radiographs of the chest and 49 had addi-
tional spinal views.
A rheumatologist (H.F.) and two orthopaedic
surgeons (P.B. and P.E.) first examined all
radiographs of the spine and chest of group I
independently, looking for DISH. The criteria
used were those of Resnick [18], and required
flowing calcification and ossification along the
anterolateral aspect of at least four contiguous
vertebral bodies and absence of extensive
'degenerative' disc disease. Radiographs which
did not completely fulfil these criteria were clas-
sified as 'probable DISH'. The individual assess-
ments were compared and where discordant, the
films were regraded by both observers together.
The pelvic radiographs of group I were evalu-
ated similarly for any ectopic bone formation
• about the prosthesis. Radiographs of spine and
pelvis were not seen simultaneously, thus mak-
ing the grading 'blind'.
The degree of ossification was defined accord-
ing to the scale of Brooker (Table I) [4, 7]. This
refers to ossification situated between the
greater trochanter and the upper border of the
acetabulum, and was adequate since changes
develop laterally in 94% [3] (Fig. 2).
All group //-patients had an AP radiograph of
the pelvis 1 year after operation but views of the
spine were not routinely obtained.
Clinical investigation
In group II, we graded patients' hip pain as
none, slight, moderate or severe 1 year post-
operatively and measured their maximal hip
flexion as >90°, 70-90°, 30-70° or <30°.
RESULTS
The radiological prevalence of DISH was
38/204 (19%) (Table II). In subgroup la the
prevalence of DISH was 25%, higher than in the
subgroup Ib (13%). In more than half of the
patients in subgroup Ib the diagnosis of DISH
had to be made from a chest radiograph. DISH
was more frequent in men than in women.
Table III shows the frequency of the different
degrees of postoperative ossification (0-FV).
The main findings are illustrated in Fig. 3 and
74% of 38 DISH probands formed postoperative
grade I-IV ossification, compared with only
58% of the 151 non-DISH probands. The differ-
ence was not significant (x2 = 2.65, p = 0.1).
When only the more severe grades III and IV
were compared, there were 29% in the DISH-
probands and 10% in non-DISH-probands (x2 =
7.72, p < 0.01).
The correlations between postoperative
ossification, pain and reduced ROM are shown
for group II in Fig. 4. Of patients with no or
Fio. 2.—Formation of ectopic ossification (grade III—IV,
after Brooker) following total hip arthroplasty.
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TABLE II
PREVALENCE OF DISH (SUBGROUPS IA, IB, TOTAL GROUP
I) IN 204 PATIENTS UNDERGOING TOTAL HIP
ARTHROPLASTY
No. (%) Group Ia Group Ib Total
Total
Men
DISH
Men
Non-DISH
DISH probable
91
51
23
18
61
7
(100)
(56)
(25)
(78)
(67)
(8)
113
70
15
11
90
8
(100)
(62)
(13)
(73)
(80)
(7)
204
121
38
29
151
15
(100)
(59)
(19)
(76)
(74)
(7)
TABLE III
FREQUENCY OF ECTOPIC BONE FORMATION FOLLOWING HIP
ARTHROPLASTY IN PATIENTS WITH DISH AND WITHOUT
DISH (CLASSIFICATION I-IV AFTER BROOKER)
Class
0
I
II
III
IV
Total
DISH
no
10
13
4
6
5
38
. (%)
(26)
(34)
(11)
(16)
(13)
(100)
Non-DISH
no
64
52
20
11
4
151
(42)
(35)
(13)
(7)
(3)
(100)
DISH prob.
no
3
7
0
5
0
15
• (%)
(20)
(47)
(33)
(100)
Total
no
77
72
24
22
9
204
. (%)
(38)
(35)
(12)
(11)
(4)
(100)
slight ossifications (classes 0-11), 4% experi-
enced moderate or severe pain. In patients with
marked ossification (classes III-IV) the fre-
quency was 10%. Postoperative flexion of less
than 70° was found in 6% of gTades 0-11 and in
26% of grades III-IV. Both findings were statis-
tically significant (x2 = 9.8, p < 0.01; x2 = 54.19,
p < 0.001, respectively).
DISCUSSION
The prevalence of spinal DISH in 19% of our
population agrees with previous published
studies of similar ages [7, 11, 12], as does the
greater prevalence of ossification in men [2,3,
10, 11].
Severe postoperative ectopic bone formation
around the hip arthroplasty was three times
more frequent in those with spinal DISH.
Irrespective of DISH, other authors have noted
postoperative ossification in 10% of patients
[3,8].
This threefold increased frequency in DISH-
probands supports the hypothesis that DISH
predisposes to ectopic bone formation as part of
a generalized 'ossifying diathesis'. Blasingame et
al. [7] suggested a correlation between vertebral
hyperostosis and ectopic bone formation based
on a small series of patients. Jacqueline [16]
found ossification in 57 of 67 subjects with
DISH, but in only 10 of 33 controls. The severity
of these ossifications and the criteria used for the
diagnosis of DISH were not given. Pilet et al.
[11] in a similar study, used less rigorous criteria
for DISH and found 22.4% postoperative
ossification in subjects with DISH and 9.6% in
controls (grades III-IV), and this is in accord
with our results.
Our second question concerned the clinical
significance of ectopic ossification. Others have
suggested a relationship with pain or impaired
hip function [6-8,10,19, 20] and Pilet et al. [11]
found a favourable postoperative ROM in 66%
of males with DISH compared with 83 % in those
without. They concluded that DISH does not
contra-indicate total hip replacement.
Our results indicate that ectopic bone forma-
tion about the hip is associated less with pain
than with functional impairment. We noted
moderate and severe pain in our group II of 1325
arthroplasties and this was significantly more
frequent in marked ossification (10% versus 4%
in controls). However, this is not a striking prev-
alence. Restricted flexion of less than 70° was
found in 26% of 'ossifying' patients versus 6% in
'non-ossifying'.
We may conclude that approximately 30% of
patients with DISH develop serious ectopic
bone formation following hip replacement and
so
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FIG. 3.—Frequency (percentage) of postoperative ectopic
bone formation in DISH and non-DISH probands.
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FIG. 4.—Correlation of degree of ossification with pain
and reduced ROM 1 year after hip arthroplasty (group II,
n = 1325).
190 BRITISH JOURNAL OF RHEUMATOLOGY VOL. XXVII NO. 3
70% will remain free. Only 25% of those with
ectopic bone show important loss of ROM and
only 6% develop serious pain. This means that
only 7.5% of all patients with DISH suffer from
restricted ROM and 1.8% from pain. This low
risk does not justify the use of drugs in an
attempt to prevent ossification. Bisphospho-
nates have proved relatively effective in this situ-
ation, but the recommended 4 months of
treatment is both expensive and may cause side-
effects [21-23]. Prevention should be confined to
patients with a history of severe ossification of
the other hip or other articulations.
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